Premium
Jessner's solution vs . 30% salicylic acid peels: a comparative study of the efficacy and safety in mild‐to‐moderate acne vulgaris
Author(s) -
Dayal Surabhi,
Amrani Ashish,
Sahu Priyadarshini,
Jain Vijay Kumar
Publication year - 2017
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.12266
Subject(s) - acne , medicine , papule , salicylic acid , dermatology , clinical efficacy , significant difference , keratolytic , surgery , lesion , biology , genetics
Summary Introduction Chemical peeling is a well‐identified therapeutic modality for acne vulgaris ( AV ). Jessner's solution ( JS ) is a known peeling agent for acne since more than 100 years. Salicylic acid ( SA ) peel is a well‐established peeling agent for acne. There is paucity of literature comparing the current peeling agents of choice, that is, SA with the older peeling agents, that is, JS for acne. Objective To compare the efficacy and safety of 30% SA vs . JS peels in treatment of mild‐to‐moderate facial acne in Indian patients. Materials and Method A total of 40 patients with mild‐to‐moderate AV were enrolled for 12 weeks and were randomly divided into two groups: group 1, 30% SA peels and group 2, JS peels were performed 2 weeks apart with total of six peels in 12‐week duration. Clinical improvement was assessed objectively using Michaelsson acne scores ( MAS ) and clinical photographs. Side effects were observed at each visit. Results At the end of therapy, improvement in MAS and percentage decrease in MAS were significantly higher in group 1 as compared to group 2. Likewise, decrease in mean comedone counts in group 1 was significantly higher as compared to group 2. However, there was no statistically significant difference in the decrease in mean papule and pustule counts between the two groups. Both the groups tolerated the peels well. Conclusion Thus, 30% SA peels were more effective than JS peels in treatment of noninflammatory lesions, that is, comedones and in overall improvement of mild‐to‐moderate facial acne vulgaris.